X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-10 | PRVB | Leon Francisco | Chief Scientific Officer | S - Sale+OE | $10.09 | -75,985 | 2,573,000 | -3% | -$766,549 | |||||
2023-02-10 | PRVB | Hoitt Jason | Chief Commercial Officer | S - Sale | $10.00 | -4,500 | 0 | -100% | -$45,005 | ||||||
| DM | 2023-02-10 | PRVB | Palmer Ashleigh | Dir, CEO | S - Sale+OE | $10.09 | -75,835 | 2,570,050 | -3% | -$765,003 | |||||
| D | 2023-01-18 | PRVB | Palmer Ashleigh | Dir, CEO | S - Sale+OE | $10.27 | -24,165 | 2,570,050 | -1% | -$248,063 | |||||
| D | 2023-01-18 | PRVB | Leon Francisco | Chief Scientific Officer | S - Sale+OE | $10.27 | -24,015 | 2,573,000 | -1% | -$246,584 | |||||
2023-01-18 | PRVB | Sessa Capital (Master), L.P. | 10% | S - Sale | $9.40 | -3,000,000 | 11,879,023 | -20% | -$28,200,000 | ||||||
| D | 2022-12-29 | PRVB | Leon Francisco | Chief Scientific Officer | S - Sale+OE | $10.26 | -187,000 | 2,573,000 | -7% | -$1,918,601 | |||||
| D | 2022-12-27 | PRVB | Leon Francisco | Chief Scientific Officer | S - Sale+OE | $10.00 | -10,674 | 2,573,000 | 0% | -$106,740 | |||||
| DM | 2022-12-22 | PRVB | Leon Francisco | Chief Scientific Officer | S - Sale+OE | $10.00 | -1,943 | 2,573,000 | 0% | -$19,431 | |||||
2021-12-03 | PRVB | Ramos Eleanor | Chief Medical Officer | P - Purchase | $6.49 | +5,201 | 70,000 | +8% | +$33,765 | ||||||
2021-11-30 | PRVB | Palmer Ashleigh | Dir, CEO | P - Purchase | $6.66 | +3,750 | 2,570,050 | 0% | +$24,990 | ||||||
2021-11-24 | PRVB | Leon Francisco | Chief Scientific Officer | P - Purchase | $7.24 | +5,550 | 2,573,000 | 0% | +$40,188 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |